ArticleBMC geriatrics2025
Risk factors for 30-day COVID-19 mortality among people living with dementia in Alberta, Canada: a retrospective cohort study.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople living with dementia (PLWD) were disproportionately impacted by the COVID-19 pandemic, experiencing high mortality rates in the initial waves. However, factors contributing to their increased risk of death following COVID-19 infection remain unclear. Given that PLWD are a heterogenous population with varying susceptibility to negative health outcomes, this study aimed to identify independent factors associated with 30-day COVID-19 mortality among PLWD and vulnerable subgroups of PLWD.
methodsWe conducted a retrospective cohort analysis using administrative data from March 1st 2020 to December 1st 2020, in Alberta, Canada. We examined the association between an outcome variable created to examine mortality in the 30-days following COVID-19 infection and factors related to the demographics and health (e.g., age, comorbidities), health service use (e.g., past physician utilization), and environment (e.g., community or long-term care) of PLWD in our study cohort and subgroups of our study cohort based on age, sex, and living setting (community, long-term care).
resultsAmong our study cohort of PLWD (N = 1526), 28% of individuals died within 30 days following COVID-19 infection. After adjusting for confounders, increasing age (AOR = 2.38, 95% CI: 1.12-5.06), male sex (AOR = 2.30, 95% CI: 1.76-3.01), and living in long-term care (AOR = 5.91, 95% CI: 4.49-7.79) were associated with a higher risk of 30-day COVID-19 mortality. Additionally, congestive heart failure, diabetes with complications, and renal failure were linked to mortality among certain subgroups of PLWD.
conclusionsThe 30-day COVID-19 case fatality rate was high among PLWD. PLWD who were older, male, and living in long-term care were at the greatest risk. The findings of this study demonstrate that specific groups of PLWD, based on both demographic and site-of-care-related factors, would benefit most from improved attention in future infectious disease public health planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.